Veterinary Medicines

CEVAC Transmune IBD vakcina A.U.V.

Authorised
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
  • Immunoglobulins against Avian infectious bronchitis virus, Avian
Download as PDF

Product identification

Medicine name:
CEVAC Transmune IBD vakcina A.U.V.
Active substance:
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
  • Immunoglobulins against Avian infectious bronchitis virus, Avian
Target species:
  • Chicken (hen)
Route of administration:
  • In ovo
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
    1.80
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)/dose
  • Immunoglobulins against Avian infectious bronchitis virus, Avian
    20.00
    virus neutralising unit(s)
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • In ovo
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva-Phylaxia Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: